In pleading guilty, Mangione admitted to following UnitedHealth executive Brian Thompson and then shooting him.

Meghana Keshavan covers biotech and contributes to The Readout newsletter. Today, we’re looking at a new multiple myeloma approval for Bristol Myers Squibb, PBMs embracing TrumpRx price comparisons, ...

Katie covers the impact of health technology on patients, clinicians, and businesses. Her stories explore the price tag of clinical AI, digital health at the FDA, and the boom in direct-to-consumer ...

Methadone clinics don't have to be as rigid in how they dispense opioid addiction medicine. Some, though not all, are ...

The default to biomedical responses means that clinics and hospitals are increasingly absorbing the costs of social problems, ...

How can we better reach out to people facing Medicaid renewal deadlines and support them through the paperwork requirements?

Seven months after the launch of its own low-cost insulin brand, California has distributed more than 120,000 five-pen packs ...

Casey’s reporting examines the use of artificial intelligence by providers and insurers. The Federal Trade Commission is examining Epic Systems Corp., the nation’s largest vendor of electronic health ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...

Pre-biopsy MRI is standard outside the U.S., but the latest data show such scans were done in only about a third of U.S.

Preparedness cannot mean optimizing every investment for yesterday's epidemic,” write Krutika Kuppalli and Placide Mbala.